UCB (Union chimique belge) - Company & Market Research Reports

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.


Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market - Product Thumbnail Image

Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market

  • Report
  • 125 Pages
From
Global Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential - Forecast to 2023 - Product Thumbnail Image

Global Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential - Forecast to 2023

  • Report
  • 120 Pages
From
The World Market for Prescription Arthritis Treatments (NSAIDs, DMARDs, BRMs and Immunosuppressants) - Product Thumbnail Image

The World Market for Prescription Arthritis Treatments (NSAIDs, DMARDs, BRMs and Immunosuppressants)

  • Report
  • 150 Pages
From
Global Gout Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Gout Therapeutics Market 2016-2020

  • Report
  • 59 Pages
From
Cimzia 2016 U.S Promotional Report - Product Thumbnail Image

Cimzia 2016 U.S Promotional Report

  • Report
  • 22 Pages
From
Axial Spondyloarthritis Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Axial Spondyloarthritis Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 68 Pages
From
The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis - Product Thumbnail Image

The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis

  • Report
  • 104 Pages
From
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update

  • Report
  • 462 Pages
From
Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies - 2016 Update

  • Report
  • 124 Pages
From
Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential - Product Thumbnail Image

Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential

  • Report
  • 199 Pages
From
Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020 - Product Thumbnail Image

Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020

  • Report
  • 98 Pages
From
US Market Report for Psoriasis Immunology Drugs 2018 - MedCore - Product Thumbnail Image

US Market Report for Psoriasis Immunology Drugs 2018 - MedCore

  • Report
  • 930 Pages
From
Psoriasis - Pipeline Review, H1 2018 - Product Thumbnail Image

Psoriasis - Pipeline Review, H1 2018

  • Report
  • 709 Pages
From
Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016 - Product Thumbnail Image

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016

  • Report
  • 294 Pages
From
Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016 - Product Thumbnail Image

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016

  • Report
  • 334 Pages
From
Chronic Plaque Psoriasis - Pipeline Review, H2 2015 - Product Thumbnail Image

Chronic Plaque Psoriasis - Pipeline Review, H2 2015

  • Report
  • 125 Pages
From
Moderate Psoriasis - Pipeline Review, H1 2015 - Product Thumbnail Image

Moderate Psoriasis - Pipeline Review, H1 2015

  • Report
  • 137 Pages
From
Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2015 - Product Thumbnail Image

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2015

  • Report
  • 235 Pages
From
Chronic Plaque Psoriasis - Pipeline Review, H1 2015 - Product Thumbnail Image

Chronic Plaque Psoriasis - Pipeline Review, H1 2015

  • Report
  • 109 Pages
From
Antibody Drugs Market Analysis: By Disease Cure; and By Geography - With Forecast 2016-2021 - Product Thumbnail Image

Antibody Drugs Market Analysis: By Disease Cure; and By Geography - With Forecast 2016-2021

  • Report
  • 135 Pages
From
Loading Indicator
adroll